pubmed.ncbi.nlm.nih.gov

Hallucinogen-Induced Persisting Perception Disorder: A Case Report - PubMed

  • ️Sun Jan 01 2023

Case Reports

. 2023 Sep 30;15(9):e46262.

doi: 10.7759/cureus.46262. eCollection 2023 Sep.

Affiliations

Case Reports

Hallucinogen-Induced Persisting Perception Disorder: A Case Report

Javairia Ayyub et al. Cureus. 2023.

Abstract

Hallucinogen-persisting perception disorder (HPPD), also known as acute hallucinogen-induced psychosis or informally known as "flashbacks," is an unusual condition experienced by patients due to the use of different hallucinogenic substances. Hallucinogen-persisting perception disorder causes many symptoms, predominantly persistent visual perception distortion instead of intermittent distortion. Although different hallucinogens could cause HPPD, lysergic acid diethylamide (LSD) and LSD-like properties seem to be the most common hallucinogens causing the symptoms. In our case report, the patient is a 28-year-old Caucasian male with a long psychiatric and social history of polysubstance use using LSD and cannabis. He started experiencing many of the classic symptoms of HPPD seven months after stopping LSD. The diagnosis is suspected by ruling out all other possible underlying causes with the help of several laboratory and imaging tests. Despite having an extensive psychiatric history of illnesses, the patient's symptoms failed to improve with antipsychotics, confirming that the symptoms were not only due to mental illness. Although supposedly the first-line treatment for HPPD is the use of alpha-2 adrenergic drugs such as clonidine and benzodiazepines, we started to witness improvement in patient's symptoms with the use of lamotrigine, which is the gold standard in treating perceptual disturbance in time and space.

Keywords: alpha-2 adrenergic agonists; antiepileptic medications; benzodiazepines; hallucinogen persisting perception disorder; lysergic acid diethylamide; visual perception distortion.

Copyright © 2023, Ayyub et al.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Anteroposterior and lateral views of chest X-ray and an MRI of the brain.

Similar articles

References

    1. The “endless trip” among the NPS users: psychopathology and psychopharmacology in the hallucinogen-persisting perception disorder. A systematic review. Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F. Front Psychiatry. 2017;8:240. - PMC - PubMed
    1. Hallucinogen persisting perception disorder. [ Aug; 2023 ]. 2023. https://eyewiki.org/Hallucinogen_Persisting_Perception_Disorder https://eyewiki.org/Hallucinogen_Persisting_Perception_Disorder - PMC - PubMed
    1. Hallucinogen persisting perception disorder: etiology, clinical features, and therapeutic perspectives. Martinotti G, Santacroce R, Pettorruso M, et al. Brain Sci. 2018;8:47. - PMC - PubMed
    1. Delgado J. Waltham, MA: UpToDate; 2023. Intoxication From LSD and Other Common Hallucinogens.
    1. Drug Enforcement Administration, U.S. Department of Justice. Drugs of Abuse: A DEA Resource Guide. 2020 Edition. Springfield, VA: Drug Enforcement Administration; 2017.

Publication types

LinkOut - more resources